Half-dose photodynamic therapy for chronic central serous chorioretinopathy
Purpose: To report the outcomes of half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: A chart review of patients with chronic CSC who had received half-dose verteporfin PDT (3 mg/m2) was performed. The main outcome measures were resolution...
Main Authors: | Masood Naseripour, Khalil Ghasemi Falavarjani, Ahad Sedaghat, Arezoo Karimi Moghaddam, Sadaf Nasserisina, Sayyed Amirpooya Alemzadeh |
---|---|
Format: | Article |
Language: | English |
Published: |
Knowledge E
2016-01-01
|
Series: | Journal of Ophthalmic & Vision Research |
Subjects: | |
Online Access: | http://www.jovr.org/article.asp?issn=2008-322X;year=2016;volume=11;issue=1;spage=66;epage=69;aulast=Naseripour |
Similar Items
-
Fundus Autofluorescence after Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy
by: Kyoko Fujita, et al.
Published: (2020-12-01) -
Morphological Changes and Prognostic Factors before and after Photodynamic Therapy for Central Serous Chorioretinopathy
by: Yu Wakatsuki, et al.
Published: (2021-01-01) -
Short-Term Choriocapillaris Changes in Patients with Central Serous Chorioretinopathy after Half-Dose Photodynamic Therapy
by: Marco Nassisi, et al.
Published: (2017-11-01) -
Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
by: Maria G. Kotoula, et al.
Published: (2012-06-01) -
Long term outcomes for patients treated with half-fluence photodynamic therapy for chronic central serous chorioretinopathy: a case series
by: Jennifer Doyle, et al.
Published: (2018-02-01)